ADDITIONAL INFO

Orforglipron — Small-Molecule GLP-1 Receptor Agonist (Research Compound)

Orforglipron is an investigational small-molecule compound that functions as a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist. In preclinical and translational research settings, GLP-1 receptor signaling is examined for its role in metabolic regulation, glucose homeostasis, and energy balance. Unlike traditional peptide-based GLP-1 agonists, Orforglipron’s small-molecule structure supports oral bioavailability and stability in laboratory studies.

Product Details

• Compound Name: Orforglipron (LY-3502970)

• Form: Oral 7 mg capsules

• Purity: ≥99% (Certificate of Analysis available)

• Intended Use: Laboratory research applications — not for human or veterinary use

• Manufactured in: GMP-certified research facility

Key Features

• Designed to interact with GLP-1 receptor pathways involved in metabolic and glucose signaling models

• Oral, non-peptide design supports consistent experimental administration

• Stability at room temperature without cold-chain requirements in research workflows

Storage & Handling

• Store in a cool, dry place prior to use

• Protect from heat, light, and moisture

• Use aseptic technique as required in laboratory protocols

Research Use Notice:
Orforglipron is provided strictly for laboratory research purposes only. It is not intended for human or animal consumption, diagnostic, medical, or therapeutic applications.